Voting and Nonvoting Consumer Representative Members on Public Advisory Committees and Panels; Notice of Public Meeting, 15714 [2010-6967]

Agencies

• Food and Drug Administration
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 75, Number 60 (Tuesday, March 30, 2010)]
[Notices]
[Page 15714]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-6967]



[[Page 15714]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]


Voting and Nonvoting Consumer Representative Members on Public 
Advisory Committees and Panels; Notice of Public Meeting

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice of public meeting.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing a public 
meeting for individuals and groups interested in nominating voting and 
nonvoting consumer representatives to FDA advisory committees and 
panels. This public meeting also is for individuals interested in 
serving as voting and nonvoting representatives of FDA advisory 
committees and panels. The purpose of the public meeting is to inform 
individuals and groups with consumer interests on how to participate in 
the nomination and selection process for members representing consumer 
interests on advisory committees, provide information on the structure 
and function of advisory committees seeking individuals to serve as 
consumer representatives, and update individuals and consumer groups 
and individuals on current committee vacancies.
    Date and Time: The public meeting will be held on April 30, 2010, 
from 8:15 a.m. to approximately 4:30 p.m.
    Location: The public meeting will be held at the Food and Drug 
Administration, Center for Drug Evaluation and Research Advisory 
Committee Conference Room, rm. 1066, 5630 Fishers Lane, Rockville, MD. 
Please use the lower entrance, which faces Parklawn Drive. Visitor 
badges will be held at the guard station at the entrance to the 
building. Participants will need a picture identification to pick up 
their badge. Public parking is not available at the 5630 Fishers Lane 
location. A public parking lot is available on Fishers Lane across from 
the Parklawn Building at 5600 Fishers Lane, and additional public 
parking is available at the Twinbrook Metro Station located several 
blocks west of the meeting location.
    Contact Person: Doreen Brandes, Office of the Commissioner (HF-4), 
Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 
301-827-8858, FAX: 301-827-1041, or e-mail: Doreen.Brandes@fda.hhs.gov. 
After April 15, 2010, the contact person's location and contact 
information will change. All correspondence should be mailed to Doreen 
Brandes, Office of the Commissioner, 10903 New Hampshire Ave., Bldg. 
32, rm. 5103, Silver Spring, MD 20993-0002, 301-796-8858, FAX: 301-847-
8640, or e-mail: Doreen.Brandes@fda.hhs.gov.
    Registration: Register by e-mail or fax to the contact person no 
later than April 23, 2010. Provide complete information for each 
attendee, including name, title, organization's name, address, e-mail, 
and telephone and fax numbers
    If you need special accommodations due to a disability, please 
contact Doreen Brandes (see Contact Person) at least 7 days in advance.

SUPPLEMENTARY INFORMATION:

I. Criteria for Members

    FDA believes that persons nominated for membership as a consumer 
representative on the committee/panels should meet the following 
criteria: (1) Demonstrate ties to consumer and community-based 
organizations, (2) be able to analyze technical data, (3) understand 
research design, (4) be able to discuss benefits and risks, and (5) be 
able to evaluate the safety and efficacy of products under review. The 
consumer representative represents the consumer perspective on issues 
and actions before the advisory committee; serves as a liaison between 
the committee and interested consumers, associations, coalitions, and 
consumer organizations; and facilitates dialogue with the advisory 
committees on scientific issues that affect consumers.

II. Nomination Procedures

    When individuals are nominated to serve as consumer representatives 
on FDA advisory committee and panels, all nominations should include a 
cover letter, a curriculum vita or resume (that includes the nominee's 
office address, telephone number, and e-mail address), and a list of 
consumer or community-based organizations for which the candidate can 
demonstrate active participation. Nominations will specify the advisory 
committee(s)or panel(s) for which the nominee is recommended. Any 
interested person or organization may nominate one or more qualified 
persons for membership as consumer representatives on the advisory 
committee/panels. Self-nominations are also accepted. Potential 
candidates will be required to provide detailed information concerning 
such matters as financial holdings, employment, and research grants 
and/or contracts to permit evaluation of possible sources of a conflict 
of interest. The nomination should specify the committees/panels of 
interest. The term of office is up to 4 years, depending on the 
appointment date.
    Additional background information regarding the topics for the 
public meeting will be available 5 days before the meeting and may be 
found at: https://www.fda.gov/AdvisoryCommittees/default.htm (look for 
link to Advisory Committee Public Meeting for Consumer 
Representatives.)

    Dated: March 24, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-6967 Filed 3-29-10; 8:45 am]
BILLING CODE 4160-01-S